RA
SLGC

Royce & Associates’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Royce & Associates’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-92,293
Closed -$221K – 954
2023
Q3 		$221K Buy
92,293
+32,823
+55% +$72.7K ﹤0.01% 870
2023
Q2 		$137K Buy
59,470
+6,370
+12% +$18K ﹤0.01% 893
2023
Q1 		$135K Buy
53,100
+22,500
+74% +$64.5K ﹤0.01% 897
2022
Q4 		$76.8K Buy
+30,600
New +$85.4K ﹤0.01% 894

Other funds holding SLGC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royce & Associates's SLGC Position: Q4 2023 in Review

Royce & Associates sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 92,293 shares — an estimated $221K sold.

Royce & Associates first reported a position in SLGC in Q4 2022 and held it in 4 quarters. The position peaked at $221K in Q3 2023. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • Royce & Associates reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royce & Associates sold 92,293 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $221K.
  • Royce & Associates first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 4 quarters.
  • Royce & Associates's SomaLogic, Inc. Class A Common Stock position peaked at $221K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on Royce & Associates's 13F filing for Q4 2023, filed 12 Feb 2024.